Evaluating a sequential treatment strategy for recalcitrant warts: A time-dependent comparative study - 18/06/26
Doi : 10.1016/j.jaad.2026.02.122
Byung Ho Oh, MD, PhD ⁎ 
Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
∗ Correspondence to: Byung Ho Oh, MD, PhD, Department of Dermatology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Department of Dermatology Yonsei University College of Medicine 50-1 Yonsei-ro Seodaemun-gu Seoul 03722 Korea
Key words : acitretin, cidofovir, cryotherapy, recalcitrant warts, surgery, treatment strategy
Plan
| Funding sources: This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (RS-2023-00244637). MID (Medical Illustration & Design), as a member of the Medical Research Support Services of Yonsei University College of Medicine, provided excellent support with medical illustration. |
|
| Patient consent: The study was conducted retrospectively using medical records, and institutional review board (IRB) approval was obtained. |
|
| IRB approval status: Reviewed and approved by the Institutional Review Board of Yonsei University Severance Hospital; approval #4-2025-0848. |
© 2026
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 95 - N° 1
P. 235-237 - juillet 2026 Retour au numéro
Article précédent
- Association of doxycycline use for acne with sexually transmitted infection outcomes: A TriNetX retrospective cohort study
- Richard J. Moraga, Hannah L. Cole, Mitchell Hanson, Lisa Y. Shen, John S. Barbieri, John G. Zampella
- Alopecia after glucagon-like peptide-1 agonist therapy: A TriNetX Database active comparator retrospective cohort study
- Kyle C. Lauck, Areeba Ahmed, Stanislav N. Tolkachjov
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?